At Rx Remedies, Inc. we believe in just doing things right. There is currently no regulatory oversight in the CBD industry, which means any existing testing to ensure the quality and dosage of CBD-based products lack the proper safety regulations and quality standards.
We formed Rx Remedies, Inc. to create our own standards of quality and effectiveness, and to redefine the true meaning of medicine. Instead of prescription drugs and harmful substances, we want to help people take control of their own health by using natural, plant-based products backed by medicinal science. Our products go beyond the therapeutic benefits of CBD by including organic terpenes and plant extracts to maximize the effect of plant-based medicine.
The Rx Remedies team includes a highly experienced medical team to ensure pharmaceutical-grade formulation of all products. Each and every ingredient is purposeful (we use no fillers), and is formulated by our Chief Science Officer, a board-certified toxicologist and pharmacologist with over a decade of experience in cannabis research. By formulating each product with the utmost precision, all of which are supported by medicinal science, we ensure not only a higher-quality product, but also a higher concentration, which ensures maximum absorption. This means our products are of the highest efficacy available on the market today.
Our team of CBD-enthusiasts are not only passionate about providing the highest-quality, CBD-based products, but they also bring years of experience and expertise to everything we do at Rx Remedies, Inc. Meet our super-star team:
John Powers, PhD, MBA, MD, Chief Executive Officer – U of MD undergrad and graduate degrees in microbiology and business. John has pharmaceutical manufacturing, medical product development, and FDA clinical trials experience.
James “Tracy” Taylor, PhD, DABT (Diplomate Am. Board of Toxicology), Chief Science Officer – Georgia College, Ph.D. from Tulane University. Pharmacologist and board-certified toxicologist. Tracy developed the company’s proprietary products.
Brent Berisford, MS, Chief Business Development Officer – WV Wesleyan graduate chemistry & biology, MS in environmental science from WV University. Unparalleled ability to connect business and people.
Meredith Priddy, Chief Marketing Officer – Towson University BS in English and Business Writing with a decade of experience in the cannabis industry. Develops and coordinates the company’s new products, plus tends to all sales and marketing efforts.
Daniel Powers, MBA, Chief Operations Officer – Shenandoah University BS in Business Administration, then MBA. Has experience in FDA regulated medical device manufacturing, accounting systems, operations and inventories.
R. Hartman “Hart” Roemer, Esq., General Councel – University of Delaware undergraduate and school of law. Admitted in MD, former Assistant Attorney General. Three decades legal experience in small company development, and corporate tax knowledge
Harriett Kamendi, PhD – Professor, neuro-scientist, and opiate addiction specialist. Integral to clinical trials.
Kathleen Kennedy, PhD – Professor, Dir. Life Sciences U of MD, geneticist. Integral in the clinical trials and employee scientific training
Daniel Zang, PhD, Esq. – Patent attorney, medical product development, biotechnology & FDA specialist. Responsible for intellectual properties, legal matters, and FDA submissions.